Pilot study of two new injectable bulking agents for the treatment of faecal incontinence

Objective The use of injectable bulking agents for passive faecal incontinence appears to provide reasonable short‐term results. However experience with different agents is limited. We report on the outcome of injections with new bulking agents. Method Each patient received injections of either Bulkamid^TM (hydrogel cross‐linked with polyacrylamide) or Permacol^TM (porcine dermal collagen). Assessment included clinical evaluation, anorectal physiological testing, endoanal ultrasonography and questionnaires including the St Mark's Incontinence Score, one week bowel diary card, the Faecal Incontinence Quality of Life Scale and the Short Form‐36 (SF‐36) health survey. Follow up was at 6 weeks and 6 months, with a further telephone review at a median of 19 months (range 14–22). Results Ten patients (nine female), median age 68 years (range 45–79), were enrolled. St Mark's incontinence score (0 = best, 24 = worst) was 15 (range 11–24) at baseline, 12.5 (range 3–18) at 6 weeks and 14 (range 6–22) at 6 months. A 1‐week bowel diary and SF‐36 forms also showed temporary improvement but this was not sustained beyond 6 weeks. Conclusion Bulkamid^TM and Permacol^TM injections did not have a major effect on faecal incontinence.     

SVN薄皮瓣技术在大面积皮肤撕脱伤修复中的应用

目的：探索治疗大面积皮肤撕脱伤的最佳方法。方法：采用真皮下血管网（SVN）薄皮瓣技术治疗大面积皮肤撕脱伤25例,结果：受伤部位功能和外观得到比较满意的恢复,结论：SVN薄皮瓣技术是治疗皮夫撕脱作的最佳方法之一。     

转化生长因子-β和碱性成纤维细胞因子在儿童原发性局灶节段性肾小球硬化肾组织中的表达

目的：通过检测转化生长因子-β（TGF-β）和碱性成纤维细胞生长因子（bFGF）在儿童原发性局灶节段性肾小球硬化（FSGS）肾组织中的表达情况,并分析其与肾小管间质病理变化的关系,以了解TGF-β与bFGF在原发性FSGS发生发展中的作用。方法：选择肾活检明确诊断为原发性FSGS患儿的肾组织共43例,其中不伴有肾小管间质病变的FSGS肾组织共16例,设为实验1组;伴有肾小管间质病变的FSGS肾组织共27例,为实验2组。另将同期因孤立性血尿入院肾活检证实为非FSGS、病理改变较轻的肾组织作为对照组,共17例。采用免疫组化法检测细胞/生长因子TGF-β、bFGF在各组中的表达。通过方差分析（ANOVA）和相关分析法分析细胞/生长因子的表达与FSGS肾组织病理变化的关系以及细胞/生长因子之间的相互作用关系。结果：TGF-β、bFGF在各组肾组织中均有表达,表达量在对照组、实验1组和实验2组中依次升高,各组间的差异均具有统计学意义（P〈0.05）;且TGF-β和bFGF的表达与肾小管间质指数呈正相关,相关系数依次为0.763和0.661。此外,TGF-β和bFGF两者的表达量经相关分析也显示呈正相关,相关系数为0.587。结论：TGF-β和bFGF在原发性FSGS患儿肾组织中高表达;随着FSGS的发展,它们在肾组织中表达量不断增加,促使肾小管间质向纤维化发展,而且两者在促进肾脏纤维化具有一定的协同作用。     

脱细胞异体真皮基质在唇裂术后继发唇鼻畸形修复中的初步应用

目的:应用脱细胞异体真皮基质(AADM)矫冶唇裂术后继发畸形中的患侧鼻底塌陷、组织量不足,上唇及红唇组织量不足.方法:在矫治唇裂术后继发畸形中用AADM,按所需增加的组织量修剪.塑形为相应形态后,植入鼻底塌陷处,鼻底复合软组织深层、隆鼻术层及口轮匝肌深层.结果:本组病例共36例,均为鼻底塌陷填充,其中17例同时作AADM隆鼻及鼻尖塑形,12例同时作AADM丰唇.除7例鼻底塌陷矫正不足,3例丰唇双侧不完全对称外,效果均满意.结论:AADM作为同种异体软组织填充材料,用于唇裂术后继发畸形中组织量不足的填充,可根据患部所需随意剪裁塑形,既避免了外源合成材料填充的缺陷,又解决了切取自体组织二次损伤及美容瘢痕残留问题.     

Effect of suture material on tensile strength and complication rate in abdominal fascial defects repaired with acellular dermal matrix

Background

Repair of ventral hernias represents a challenging problem for surgeons. AlloDerm^® (LifeCell, Branchburg, NJ, USA), an acellular dermal matrix (ADM) product derived from cadaveric human skin, has gained in popularity in the management of abdominal hernias because of its ability to support neovascularization and therefore resist infection. Surgeons have traditionally used nonabsorbable suture when using ADM in this setting, perhaps because of concerns regarding wound strength. This study was undertaken to examine the influence of suture material on wound breaking strength and complication rates in abdominal wall defects closed with ADM.

Methods

Full-thickness abdominal defects were created in athymic rats and immediately repaired with an ADM interposition graft using either interrupted Prolene^® or Maxon^® suture. Complications were recorded over time and the animals were sacrificed at 1 month intervals. The abdominal repair complex was harvested and wound strength was measured using a tensiometer.

Results

There were no hernias in any of the groups. There were also no cases of major adhesions to the AlloDerm^®. Two rats in the Prolene^® group developed a stitch extrusion through the ventral skin. Wound breaking strength increased significantly from the second to third month after surgery in both suture groups (p = 0.0000, LSD test). The breaking strength of the abdominal fascia-ADM complex increased over the course of the experiment in both test groups, but no significant difference was found between the groups at any time point (p = 0.3157). At 3 months, the breaking strength of the Prolene^® group and Maxon^® group was nearly identical (27.1 N ± SD 7.4 and 29.7 N ± SD 9.6, respectively).

Conclusions

We were unable to identify a significant difference in breaking strength at the interface between ADM and normal, native fascia when using permanent versus resorbable sutures.

     

明胶降解物对大鼠真皮成纤维细胞增殖及Ⅰ型胶原蛋白分泌的影响

目的 探讨组织工程心瓣膜常用人工基质材料--明胶发生降解后的产物对大鼠真皮成纤维细胞增殖及Ⅰ型胶原蛋白分泌的影响. 方法 利用酶组合技术制备明胶降解物（gelatin hydrolysate, GH）,采用超滤的方法分离出低分子量明胶降解物组分（gelatin hydrolysate fraction, GHF）,用于5只SD大鼠真皮成纤维细胞的体外培养.采用CCK-8活细胞计数试剂盒（Cell Counting Kit-8）检测细胞的增殖情况,ELISA试剂盒检测细胞I型胶原蛋白的分泌情况. 结果 ①GHF对细胞增殖作用的浓度效应：在0.125～1.0 mg/ml浓度范围内,GHF对细胞的促增殖作用呈现先增强后减弱的趋势,在0.25 mg/ml时,细胞增殖率最大,达到（47.54±16.35）%;②GH与GHF对细胞增殖影响比较：GH与GHF均具有促进细胞增殖的作用,且在浓度为0.25 mg/ml时,促细胞增殖作用无显著差异[（27.04±15.21）% vs （39.22±15.55）%, P=0.177];③GH与GHF对细胞分泌Ⅰ型胶原蛋白影响比较：GHF组第3天时Ⅰ型胶原分泌量为（28.06±5.60）pg/105,与空白对照的（18.24±4.52）pg/105相比,有显著差异（P=0.006）,而GH组直至第6天时Ⅰ型胶原蛋白分泌量,与空白对照相比,无统计学意义（P=0.103）. 结论 分子量大小不同的明胶降解物GH与GHF均具有促进大鼠真皮成纤维细胞增殖的作用,且分子量较小的GHF还具有促进细胞I型胶原分泌的功能.     

人毛乳头细胞条件培养液治疗斑秃的临床观察

目的：人毛乳头细胞条件培养液治疗斑秃患者的临床观察。方法：用人毛乳头细胞条件培养液治疗100例斑秃患者，并分别选择其中53例和30例作去炎松组和空白组自身对照。结果：人毛乳头细胞条件培养液组、去炎松组和空白组治愈率分别为75％、51％、10％，有效率分别为97％、72％、30％，人毛乳头细胞条件培养液组其治愈率和有效率均明显高于去炎松组和空白组（P〈0．05）。结论：人毛乳头细胞条件培养液对斑秃患者有明显的治疗作用。     

血管紧张素对增生性瘢痕成纤维细胞纤维连接蛋白合成的影响

目的：探讨血管紧张素Ⅱ（AngⅡ）及其Ⅰ型、Ⅱ型受体阻断剂和钙调神经磷酸激酶（CaN）的阻滞利环胞素A（CsA）对增生性瘢痕来源的成纤维细胞纤维连接蛋白mRNA和蛋白表达的作用。方法：体外分离培养增生性瘢痕成纤维细胞，分别将一定浓度的AngⅡ（10^-9～10^-5mmol／L），和AngⅡ10^-6mmol／L加上不同阻滞剂losartan、PD123319、环胞素A（浓度均为10^-5mmol／L）加入细胞培养液中刺激48h，分别采用逆转录聚合酶链反应（RT—PCR）及Westernblot印迹方法检测增生性瘢痕成纤维细胞纤维连接蛋白（FN）的mRNA及蛋白表达。结果：体外成功地培养增生性瘢痕成纤维细胞。经AngⅡ刺激48h后，FN mRNA和蛋白表达量明显增高，增高程度与AngⅡ浓度呈正比；加入losaartan和环胞素A后，FN原mRNA和蛋白表达量较单用AngⅡ组下降，而加入PD123319后，FNmRNA和蛋白表达量较单用AngⅡ组无明显改变。结论：AngⅡ可促增生性瘢痕成纤维细胞的FN合成，可能在增生性瘢痕的发展过程中起重要作用，该作用主要通过AngⅡ的Ⅰ型受体介导完成，该作用可能与CaN信号通路有关。     

P物质抑制剂辣椒素和bFGF抗体对增生性瘢痕成纤维细胞增殖协同抑制作用的实验研究

目的：探讨P物质抑制剂-辣椒素及bFGF抗体单独或联合使用对体外培养的人体增生性瘢痕成纤维细胞增殖的影响。方法：体外培养12例增生性瘢痕组织的成纤维细胞,分别加入不同浓度的辣椒素或/和bFGF抗体,培养24h后观察细胞形态学变化,并用MTT法检测细胞增殖抑制率。结果：所有不同浓度的辣椒素（2.5,5,20,40,60,80mg/L）均能使细胞皱缩、坏死,抑制细胞增殖,其抑制作用随剂量增大而增加。中高浓度bFGF抗体（40,80mg/L）也可促使细胞皱缩、坏死,抑制细胞增殖,其抑制作用也随剂量增大而增加。辣椒素与bFGF抗体联合应用对成纤维细胞抑制作用较单独使用效果更显著（P﹤0.05）。结论：辣椒素及bFGF抗体可抑制增生性瘢痕成纤维细胞增殖,其抑制作用随浓度增加而增加,两者联合使用有协调作用,本研究结果可能在增生性瘢痕的治疗提供新的思路和手段。     

595nm激光对兔耳瘢痕成纤维细胞增殖与凋亡的影响

目的：探讨595nmVbeam激光照射对增生性瘢痕动物模型伤口愈合过程中成纤维细胞增殖与凋亡的影响。方法：成年大耳白兔20只,建立兔耳腹侧面增生性瘢痕模型,对比研究在瘢痕形成过程中595nmVbeam激光照射对兔耳瘢痕成纤维细胞的影响,采用免疫组化方法检测增殖细胞核抗原（PCNA）蛋白表达和细胞凋亡的原位检测。结果：兔耳增生性瘢痕经595nmVbeam激光照射后,按不同时间段取材进行免疫组化染色并与对照组比较,高倍镜下观察结果,显示PCNA蛋白表达明显减弱,细胞凋亡增加。结论：595nmVbeam激光照射可抑制兔耳增生性瘢痕成纤维细胞的增殖过程,诱导细胞凋亡。应用595nmVbeam激光预防和治疗瘢痕是可行的。